These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25530551)

  • 1. Prostate cancer prevalence in New South Wales Australia: a population-based study.
    Yu XQ; Luo Q; Smith DP; Clements MS; O'Connell DL
    Cancer Epidemiol; 2015 Feb; 39(1):29-36. PubMed ID: 25530551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A population-based study of breast cancer prevalence in Australia: predicting the future health care needs of women living with breast cancer.
    Yu XQ; De Angelis R; Luo Q; Kahn C; Houssami N; O'Connell DL
    BMC Cancer; 2014 Dec; 14():936. PubMed ID: 25494610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase of care prevalence for prostate cancer in New South Wales, Australia: A population-based modelling study.
    Yu XQ; Luo Q; Smith DP; Clements MS; Patel MI; O'Connell DL
    PLoS One; 2017; 12(2):e0171013. PubMed ID: 28178275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of cases with unknown stage prostate cancer in a population-based cancer registry.
    Luo Q; Yu XQ; Cooke-Yarborough C; Smith DP; O'Connell DL
    Cancer Epidemiol; 2013 Dec; 37(6):813-9. PubMed ID: 24103424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific antigen testing in Australia and association with prostate cancer incidence in New South Wales.
    Smith DP; Armstrong BK
    Med J Aust; 1998 Jul; 169(1):17-20. PubMed ID: 9695696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer and prostate-specific antigen testing in New South Wales.
    Smith DP; Supramaniam R; Marshall VR; Armstrong BK
    Med J Aust; 2008 Sep; 189(6):315-8. PubMed ID: 18803534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung cancer prevalence in New South Wales (Australia): Analysis of past trends and projection of future estimates.
    Yu XQ; Kahn C; Luo Q; Sitas F; O'Connell DL
    Cancer Epidemiol; 2015 Aug; 39(4):534-8. PubMed ID: 26070508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and future burden of incident hip fractures in New South Wales, Australia.
    Stephens AS; Toson B; Close JC
    Arch Osteoporos; 2014; 9():200. PubMed ID: 25385340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation and projections of cancer prevalence from cancer registry data.
    Verdecchia A; De Angelis G; Capocaccia R
    Stat Med; 2002 Nov; 21(22):3511-26. PubMed ID: 12407687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high?
    Feletto E; Bang A; Cole-Clark D; Chalasani V; Rasiah K; Smith DP
    World J Urol; 2015 Nov; 33(11):1677-87. PubMed ID: 25698456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of suicide in New South Wales men with prostate cancer: Analysis of linked population-wide data.
    Smith DP; Calopedos R; Bang A; Yu XQ; Egger S; Chambers S; O'Connell DL
    PLoS One; 2018; 13(6):e0198679. PubMed ID: 29897979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in prostate cancer incidence, mortality and survival in relation to prostate specific antigen testing in New South Wales, Australia.
    Luo Q; Yu XQ; Kahn C; Egger S; Patel MI; Grogan PB; Caruana M; Canfell K; Smith DP; O'Connell DL
    Cancer Epidemiol; 2022 Jun; 78():102159. PubMed ID: 35447540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second primary cancers after cancers of the colon and rectum in New South Wales, Australia, 1972-1991.
    McCredie M; Macfarlane GJ; Bell J; Coates M
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):155-60. PubMed ID: 9138657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling and calibration of the hepatitis C epidemic in Australia.
    Razali K; Amin J; Dore GJ; Law MG; HCV Projections Working Group
    Stat Methods Med Res; 2009 Jun; 18(3):253-70. PubMed ID: 19036911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of surgical care for prostate cancer in NSW, 1993-2002: rural/urban and socio-economic variation.
    Hayen A; Smith DP; Patel MI; O'Connell DL
    Aust N Z J Public Health; 2008 Oct; 32(5):417-20. PubMed ID: 18959543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence trends.
    Telesca D; Etzioni R; Gulati R
    Biometrics; 2008 Mar; 64(1):10-9. PubMed ID: 17501937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era.
    Konety BR; Bird VY; Deorah S; Dahmoush L
    J Urol; 2005 Nov; 174(5):1785-8; discussion 1788. PubMed ID: 16217287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dramatic increase in prostate cancer cases by 2021.
    Quon H; Loblaw A; Nam R
    BJU Int; 2011 Dec; 108(11):1734-8. PubMed ID: 21507185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent trends in prostate cancer testing and incidence among men under age of 50.
    Li J; German R; King J; Joseph D; Thompson T; Wu XC; Ajani U; Tai E
    Cancer Epidemiol; 2012 Apr; 36(2):122-7. PubMed ID: 22112545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-reported prevalence of prostate-specific antigen testing in South Australia: a community study.
    Pinnock CB; Weller DP; Marshall VR
    Med J Aust; 1998 Jul; 169(1):25-8. PubMed ID: 9695698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.